장기 칩 시장 규모, 점유율, 동향 및 성장 분석 보고서(2026-2034년)

The Organ On A Chip Market size is expected to reach USD 3562.95 Million in 2034 from USD 228.65 Million (2025) growing at a CAGR of 35.68% during 2026-2034.

The Global Organ On A Chip Market is experiencing rapid growth driven by advancements in biomedical research and drug development. Organ-on-a-chip technology replicates human organ functions on microfluidic devices, enabling more accurate preclinical testing. Increasing demand for alternatives to animal testing and improved drug safety evaluation is supporting market expansion. Rising research funding in biotechnology and pharmaceutical sectors is further accelerating innovation.

Key growth drivers include the growing focus on personalized medicine and precision drug screening. Pharmaceutical companies are adopting organ-on-a-chip platforms to reduce development timelines and costs. Technological advancements in microfabrication and biomaterials are enhancing device performance. Academic institutions and research organizations are also investing in this technology for disease modeling and toxicity testing.

Looking ahead, the market is expected to benefit from increased commercialization and collaboration between biotech firms and research institutions. Expanding applications in cancer research and regenerative medicine will create new opportunities. Continuous innovation in multi-organ chip systems will improve predictive accuracy. As demand for ethical and efficient drug testing methods rises, the Global Organ On A Chip Market is poised for strong long-term growth.

Our reports are meticulously crafted to provide clients with comprehensive and actionable insights into various industries and markets. Each report encompasses several critical components to ensure a thorough understanding of the market landscape:

Market Overview: A detailed introduction to the market, including definitions, classifications, and an overview of the industry's current state.

Market Dynamics: In-depth analysis of key drivers, restraints, opportunities, and challenges influencing market growth. This section examines factors such as technological advancements, regulatory changes, and emerging trends.

Segmentation Analysis: Breakdown of the market into distinct segments based on criteria like product type, application, end-user, and geography. This analysis highlights the performance and potential of each segment.

Competitive Landscape: Comprehensive assessment of major market players, including their market share, product portfolio, strategic initiatives, and financial performance. This section provides insights into the competitive dynamics and key strategies adopted by leading companies.

Market Forecast: Projections of market size and growth trends over a specified period, based on historical data and current market conditions. This includes quantitative analyses and graphical representations to illustrate future market trajectories.

Regional Analysis: Evaluation of market performance across different geographical regions, identifying key markets and regional trends. This helps in understanding regional market dynamics and opportunities.

Emerging Trends and Opportunities: Identification of current and emerging market trends, technological innovations, and potential areas for investment. This section offers insights into future market developments and growth prospects.

MARKET SEGMENTATION

By Product and Service

• Products
• Services

By Application

• Drug Discovery
• Toxicology Research
• Others

By End Use

• Academic & Research Institutes
• Pharmaceutical & Biotechnology Companies
• Others

COMPANIES PROFILED

• Emulate Inc, MIMETAS BV, Valo Health, Nortis Inc, AxoSim Inc, BICO Group AB The Bio Convergence Company, CN Bio Innovations Ltd, SynVivo Inc, The Charles Stark Draper Laboratory Inc, AlveoliX AG
• We can customise the report as per your requirements.

TABLE OF CONTENTS

Chapter 1. PREFACE

• 1.1. Market Segmentation & Scope
• 1.2. Market Definition
• 1.3. Information Procurement
  • 1.3.1 Information Analysis
  • 1.3.2 Market Formulation & Data Visualization
  • 1.3.3 Data Validation & Publishing
• 1.4. Research Scope and Assumptions
  • 1.4.1 List of Data Sources

Chapter 2. EXECUTIVE SUMMARY

• 2.1. Market Snapshot
• 2.2. Segmental Outlook
• 2.3. Competitive Outlook

Chapter 3. MARKET VARIABLES, TRENDS, FRAMEWORK

• 3.1. Market Lineage Outlook
• 3.2. Penetration & Growth Prospect Mapping
• 3.3. Value Chain Analysis
• 3.4. Regulatory Framework
  • 3.4.1 Standards & Compliance
  • 3.4.2 Regulatory Impact Analysis
• 3.5. Market Dynamics
  • 3.5.1 Market Drivers
  • 3.5.2 Market Restraints
  • 3.5.3 Market Opportunities
  • 3.5.4 Market Challenges
• 3.6. Porter's Five Forces Analysis
• 3.7. PESTLE Analysis

Chapter 4. GLOBAL ORGAN ON A CHIP MARKET: BY PRODUCT AND SERVICE 2022-2034 (USD MN)

• 4.1. Market Analysis, Insights and Forecast Product And Service
• 4.2. Products Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 4.3. Services Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 5. GLOBAL ORGAN ON A CHIP MARKET: BY APPLICATION 2022-2034 (USD MN)

• 5.1. Market Analysis, Insights and Forecast Application
• 5.2. Drug Discovery Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.3. Toxicology Research Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 5.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 6. GLOBAL ORGAN ON A CHIP MARKET: BY END USE 2022-2034 (USD MN)

• 6.1. Market Analysis, Insights and Forecast End Use
• 6.2. Academic & Research Institutes Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.3. Pharmaceutical & Biotechnology Companies Estimates and Forecasts By Regions 2022-2034 (USD MN)
• 6.4. Others Estimates and Forecasts By Regions 2022-2034 (USD MN)

Chapter 7. GLOBAL ORGAN ON A CHIP MARKET: BY REGION 2022-2034(USD MN)

• 7.1. Regional Outlook
• 7.2. North America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.2.1 By Product And Service
  • 7.2.2 By Application
  • 7.2.3 By End Use
  • 7.2.4 United States
  • 7.2.5 Canada
  • 7.2.6 Mexico
• 7.3. Europe Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.3.1 By Product And Service
  • 7.3.2 By Application
  • 7.3.3 By End Use
  • 7.3.4 United Kingdom
  • 7.3.5 France
  • 7.3.6 Germany
  • 7.3.7 Italy
  • 7.3.8 Russia
  • 7.3.9 Rest Of Europe
• 7.4. Asia-Pacific Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.4.1 By Product And Service
  • 7.4.2 By Application
  • 7.4.3 By End Use
  • 7.4.4 India
  • 7.4.5 Japan
  • 7.4.6 South Korea
  • 7.4.7 Australia
  • 7.4.8 South East Asia
  • 7.4.9 Rest Of Asia Pacific
• 7.5. Latin America Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.5.1 By Product And Service
  • 7.5.2 By Application
  • 7.5.3 By End Use
  • 7.5.4 Brazil
  • 7.5.5 Argentina
  • 7.5.6 Peru
  • 7.5.7 Chile
  • 7.5.8 South East Asia
  • 7.5.9 Rest of Latin America
• 7.6. Middle East & Africa Market Analysis, Insights and Forecast, 2022-2034 (USD MN)
  • 7.6.1 By Product And Service
  • 7.6.2 By Application
  • 7.6.3 By End Use
  • 7.6.4 Saudi Arabia
  • 7.6.5 UAE
  • 7.6.6 Israel
  • 7.6.7 South Africa
  • 7.6.8 Rest of the Middle East And Africa

Chapter 8. COMPETITIVE LANDSCAPE

• 8.1. Recent Developments
• 8.2. Company Categorization
• 8.3. Supply Chain & Channel Partners (based on availability)
• 8.4. Market Share & Positioning Analysis (based on availability)
• 8.5. Vendor Landscape (based on availability)
• 8.6. Strategy Mapping

Chapter 9. COMPANY PROFILES OF GLOBAL ORGAN ON A CHIP INDUSTRY

• 9.1. Top Companies Market Share Analysis
• 9.2. Company Profiles
  • 9.2.1 Emulate Inc
  • 9.2.2 MIMETAS B.V
  • 9.2.3 Valo Health
  • 9.2.4 Nortis Inc
  • 9.2.5 AxoSim Inc
  • 9.2.6 BICO Group AB (The Bio Convergence Company)
  • 9.2.7 CN Bio Innovations Ltd
  • 9.2.8 SynVivo Inc
  • 9.2.9 The Charles Stark Draper Laboratory Inc
  • 9.2.10 AlveoliX AG